Trisalus Life Sciences Stock Beta
| TLSI Stock | 4.56 0.17 3.87% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess TriSalus Life's long-term financial health and intrinsic value.
TriSalus | Beta | Build AI portfolio with TriSalus Stock |
TriSalus Life Sciences Company Beta Analysis
TriSalus Life's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current TriSalus Life Beta | 0.47 |
Most of TriSalus Life's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TriSalus Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
TriSalus Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for TriSalus Life is extremely important. It helps to project a fair market value of TriSalus Stock properly, considering its historical fundamentals such as Beta. Since TriSalus Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TriSalus Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TriSalus Life's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, TriSalus Life Sciences has a Beta of 0.471. This is 45.23% lower than that of the Health Care Equipment & Supplies sector and 54.71% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
TriSalus Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TriSalus Life's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TriSalus Life could also be used in its relative valuation, which is a method of valuing TriSalus Life by comparing valuation metrics of similar companies.TriSalus Life is currently under evaluation in beta category among its peers.
TriSalus Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, TriSalus Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to TriSalus Life's managers, analysts, and investors.Environmental | Governance | Social |
As returns on the market increase, TriSalus Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding TriSalus Life is expected to be smaller as well.
TriSalus Fundamentals
| Return On Equity | -4.96 | ||||
| Return On Asset | -0.61 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (0.78) % | ||||
| Current Valuation | 235.01 M | ||||
| Shares Outstanding | 49.96 M | ||||
| Shares Owned By Insiders | 42.40 % | ||||
| Shares Owned By Institutions | 19.41 % | ||||
| Number Of Shares Shorted | 642.6 K | ||||
| Price To Book | 30.29 X | ||||
| Price To Sales | 5.67 X | ||||
| Revenue | 29.43 M | ||||
| Gross Profit | 33.79 M | ||||
| EBITDA | (36.16 M) | ||||
| Net Income | (30.05 M) | ||||
| Total Debt | 23.63 M | ||||
| Book Value Per Share | (0.54) X | ||||
| Cash Flow From Operations | (40.84 M) | ||||
| Short Ratio | 5.44 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Target Price | 11.36 | ||||
| Number Of Employees | 110 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 227.84 M | ||||
| Total Asset | 23.97 M | ||||
| Retained Earnings | (279.55 M) | ||||
| Working Capital | 10.44 M | ||||
| Net Asset | 23.97 M |
About TriSalus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TriSalus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TriSalus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TriSalus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:Check out TriSalus Life Piotroski F Score and TriSalus Life Altman Z Score analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share | Quarterly Revenue Growth 0.574 | Return On Assets | Return On Equity |
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.